ENTITY

Halozyme Therapeutics (HALO US)

24
Analysis
Health CareUnited States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
more
Company Presentation04 Nov 2025 05:30
Company Presentation01 Oct 2025 20:30
Company Presentation06 Aug 2025 04:30
Company Presentation07 May 2025 04:30
Company Presentation19 Feb 2025 05:30
x